Posted on Leave a comment

Gaucher’s Disease Therapeutic Pipeline Analysis | Insights into the Latest Regulatory Approvals, Breakthroughs, Clinical/Non-Clinical Trials, Emerging Therapies, Treatment Algorithm, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 14+ key pharma and biotech companies are working on 16+ pipeline drugs in the Gaucher’s Disease therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development expected […]

Posted on Leave a comment

Diabetic Retinopathy Pipeline Assessment | Insights into the Current Therapies, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, Treatment Outlook, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 60+ key pharma and biotech companies are working on 60+ pipeline drugs in the Diabetic Retinopathy therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development expected […]

Posted on Leave a comment

Metachromatic Leukodystrophy (MLD) Market to Accelerate Substantially During the Forecast Period 2019-32 – DelveInsight | Key Companies – Takeda, Orchard Therapeutics, Magenta Therapeutics, and Others

Delveinsight Business Research LLP As per DelveInsight, the Metachromatic Leukodystrophy Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, ongoing Research and Development (R&D) activities, the rise in the number of prevalent cases, and the active participation of the global pharma and biotech giants in the […]

Posted on Leave a comment

Life Sciences and Medical Equipment Lead Healthcare to a Bullish August (WHSI, CEMI, IBIO, DNA, TTOO)

For the past month, Life Sciences (+12.38%) and Medical Equipment (+8.84%) have been the leading subindustries in the Healthcare sector.   There are several companies in these subindustries with upcoming catalysts investors should start researching and with earnings season upon us several are becoming volatile as investors react to filings creating profit opportunities. HEALTHCARE CATALYSTS […]

Posted on Leave a comment

Acute On Chronic Liver Failure (ACLF) Market to Observe Stupendous Growth During the Forecast Period 2032 – DelveInsight | Key Companies – RHEACELL, Versantis, Yaqrit, Grifols, Promethera, and Others

Delveinsight Business Research LLP As per DelveInsight, the Acute On Chronic Liver Failure (ACLF) Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, the increasing incident population, ongoing R&D activities, and the active participation of the global pharma and biotech giants in the therapeutic segment. Several […]

Posted on Leave a comment

Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Market to Register Immense Growth by 2032 – Asserts DelveInsight | Key Companies – UCB, Galapagos, Novartis, Sun Pharma, and Others

Delveinsight Business Research LLP As per DelveInsight, the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Therapeutics Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, increasing prevalent population of nr-axSpA, ongoing Research and Development (R&D) activities, and the active participation of the global pharma and biotech giants in the therapeutic […]

Posted on Leave a comment

Follicular Lymphoma Therapeutics Pipeline Assessment | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, Treatment Outlook, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Follicular Lymphoma therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development expected […]

Posted on Leave a comment

Natural Killer (NK)-Cell Lymphoma Pipeline Assessment | FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies Involved

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 100+ key pharma and biotech companies are working on 140+ pipeline drugs in the Natural Killer (NK)-Cell Lymphoma therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical […]

Posted on Leave a comment

Metastatic Colorectal Pipeline Assessment – Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical/Non-Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, nearly 140+ key pharma and biotech companies are working on 140+ pipeline drugs in the Metastatic Colorectal Cancer therapeutics landscape based on different routes of administration (RoA), Mechanism of Action (MoA) and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Yonsei Life & Health’s “KidsTen042” becomes popular as health functional food that helps increase children height

With the coronavirus pandemic spreading around the world, there has been growing attention to health more than ever before. The health functional food market in South Korea is continuing to see a steady growth from roughly KRW4.9273 trillion in 2020 to roughly KRW5.0454 trillion in 2021. This is an indication of widespread use of health […]